Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Prognostic value of mitotic counts in breast cancer of Saudi Arabian patients.

Buhmeida A, Al-Maghrabi J, Merdad A, Al-Thubaity F, Chaudhary A, Gari M, Abuzenadah A, Collan Y, Syrjänen K, Al-Qahtani M.

Anticancer Res. 2011 Jan;31(1):97-103.

PMID:
21273586
2.

Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours.

Fiets WE, Bellot FE, Struikmans H, Blankenstein MA, Nortier JW.

Eur J Surg Oncol. 2005 Mar;31(2):128-33.

PMID:
15698727
4.

In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up.

Bult P, Manders P, Straatman HM, Tjan-Heijnen VC, Beex LV, Hendriks J, Leer JW, Verbeek AL, Holland R.

Breast Cancer Res Treat. 2010 Jul;122(1):77-86. doi: 10.1007/s10549-009-0526-7. Epub 2009 Sep 17.

PMID:
19760038
5.

The prognostic relevance of estimates of proliferative activity in early breast cancer.

Heatley MK, Maxwell P, Whiteside C, Ewing P, Toner PG.

Histopathology. 2005 Jan;46(1):110-1. No abstract available.

PMID:
15656896
6.
7.

[Proliferation index and its prognostic value in invasive ductal breast carcinoma].

Falco M.

Ann Acad Med Stetin. 2009;55(1):22-30. Polish.

PMID:
20349588
8.

Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.

Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H, Abbas J, Khalife M, Boulos FI, Tawil AN, Geara FB, Salem Z, Shamseddine AA, Al-Feghali K, Shamseddine AI.

Ann Surg Oncol. 2009 Dec;16(12):3388-95. doi: 10.1245/s10434-009-0653-8.

PMID:
19655200
9.

[Mitotic index as a prognostic factor in ductal breast cancer].

Kazantseva IA, Potapov IuN, Linell' F, Sternbi N.

Arkh Patol. 1995 Mar-Apr;57(2):18-21. Russian.

PMID:
7611890
10.

Mitotic counts provide additional prognostic information in grade II mammary carcinoma.

Lynch J, Pattekar R, Barnes DM, Hanby AM, Camplejohn RS, Ryder K, Gillett CE.

J Pathol. 2002 Mar;196(3):275-9.

PMID:
11857489
11.

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.

Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.

J Surg Oncol. 2002 May;80(1):4-11.

PMID:
11967899
12.

Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia.

Ibrahim EM, Elkhodary TR, Zekri JM, Bahadur Y, El-Sayed ME, Al-Gahmi AM, Rizvi SA, Hassouna AH, Fawzy EE, Awadalla SS.

Asia Pac J Clin Oncol. 2010 Jun;6(2):130-7. doi: 10.1111/j.1743-7563.2010.01288.x.

PMID:
20565426
13.

Lymphovascular invasion, as a prognostic marker in patients with invasive breast cancer.

Gurleyik G, Gurleyik E, Aker F, Aktekin A, Emir S, Gungor O, Saglam A.

Acta Chir Belg. 2007 Jun;107(3):284-7.

PMID:
17685254
14.

The value of morphometry to classic prognosticators in breast cancer.

Baak JP, Van Dop H, Kurver PH, Hermans J.

Cancer. 1985 Jul 15;56(2):374-82.

PMID:
4005802
15.

Prognosis based on primary breast carcinoma instead of pathological nodal status.

Ménard S, Bufalino R, Rilke F, Cascinelli N, Veronesi U, Colnaghi MI.

Br J Cancer. 1994 Oct;70(4):709-12.

16.

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

Skaland I, Janssen EA, Gudlaugsson E, Klos J, Kjellevold KH, Søiland H, Baak JP.

Mod Pathol. 2007 Dec;20(12):1307-15. Epub 2007 Oct 5.

17.

Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.

Hansen S, Sørensen FB, Vach W, Grabau DA, Bak M, Rose C.

Histopathology. 2004 May;44(5):428-36.

PMID:
15139990
18.

Pathologic correlates of prognosis in lymph node-positive breast carcinomas.

Clayton F, Hopkins CL.

Cancer. 1993 Mar 1;71(5):1780-90.

PMID:
8383579
19.

[Prognostic factors in operated breast carcinoma].

Bianco V, De Benedetto A, Simeoni F, Toto A, Paris E, Chiodini S, Marchei P.

Minerva Med. 1995 Jan-Feb;86(1-2):17-20. Italian.

PMID:
7753433
20.

Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.

Baak JP, Colpaert CG, van Diest PJ, Janssen E, van Diermen B, Albernaz E, Vermeulen PB, Van Marck EA.

Eur J Cancer. 2005 Sep;41(14):2093-101.

PMID:
16153819

Supplemental Content

Support Center